
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12151525
[patent_doc_number] => 20180022789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN-PARTICLECONTAINING CELLS, METHOD FOR PRODUCING GELATIN-PARTICLE-CONTAINING CELLS, AND CELLULAR STRUCTURE'
[patent_app_type] => utility
[patent_app_number] => 15/650142
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9126
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650142
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650142 | GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN-PARTICLECONTAINING CELLS, METHOD FOR PRODUCING GELATIN-PARTICLE-CONTAINING CELLS, AND CELLULAR STRUCTURE | Jul 13, 2017 | Abandoned |
Array
(
[id] => 12449184
[patent_doc_number] => 09982248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Factor IX polypeptide mutant, its uses and method for its production
[patent_app_type] => utility
[patent_app_number] => 15/650070
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11894
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650070
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650070 | Factor IX polypeptide mutant, its uses and method for its production | Jul 13, 2017 | Issued |
Array
(
[id] => 12125091
[patent_doc_number] => 20180008677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'MODIFIED VASOACTIVE INTESTINAL PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/621320
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13706
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621320
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/621320 | MODIFIED VASOACTIVE INTESTINAL PEPTIDES | Jun 12, 2017 | Abandoned |
Array
(
[id] => 14775067
[patent_doc_number] => 20190262431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => CBL-FAMILY INHIBITOR COMPRISING A CBL-FAMILY TKB DOMAIN BINDING PEPTIDE FOR THE PREVENTION OR TREATMENT OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/307735
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307735 | CBL-FAMILY INHIBITOR COMPRISING A CBL-FAMILY TKB DOMAIN BINDING PEPTIDE FOR THE PREVENTION OR TREATMENT OF DISEASES | Jun 8, 2017 | Abandoned |
Array
(
[id] => 14309619
[patent_doc_number] => 20190144513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => THE CORE DOMAIN OF ANNEXINS AND USES THEREOF IN ANTIGEN DELIVERY AND VACCINATION
[patent_app_type] => utility
[patent_app_number] => 16/308702
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308702 | Core domain of annexins and uses thereof in antigen delivery and vaccination | Jun 7, 2017 | Issued |
Array
(
[id] => 12660385
[patent_doc_number] => 20180111961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => Purification method for divalent cation binding proteins by anion exchange chromatography
[patent_app_type] => utility
[patent_app_number] => 15/615696
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615696 | Protein purification by anion exchange chromatography | Jun 5, 2017 | Issued |
Array
(
[id] => 12119101
[patent_doc_number] => 20180002687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Methods for Enhancing Bacterial Cell Display of Proteins and Peptides'
[patent_app_type] => utility
[patent_app_number] => 15/613877
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20060
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613877 | Methods for enhancing bacterial cell display of proteins and peptides | Jun 4, 2017 | Issued |
Array
(
[id] => 13343441
[patent_doc_number] => 20180223260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => FUNCTIONALIZED NANOPARTICLES FOR THE INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES AND METHODS FOR THEIR MANUFACTURE AND USE
[patent_app_type] => utility
[patent_app_number] => 15/613197
[patent_app_country] => US
[patent_app_date] => 2017-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613197 | FUNCTIONALIZED NANOPARTICLES FOR THE INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES AND METHODS FOR THEIR MANUFACTURE AND USE | Jun 2, 2017 | Abandoned |
Array
(
[id] => 12975844
[patent_doc_number] => 20170340698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/612094
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612094 | CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF | Jun 1, 2017 | Abandoned |
Array
(
[id] => 16755355
[patent_doc_number] => 10973883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
[patent_app_type] => utility
[patent_app_number] => 16/302324
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 12586
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302324 | Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia | May 18, 2017 | Issued |
Array
(
[id] => 15850943
[patent_doc_number] => 10640737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Cleaning composition
[patent_app_type] => utility
[patent_app_number] => 15/591676
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7283
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591676
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591676 | Cleaning composition | May 9, 2017 | Issued |
Array
(
[id] => 13944681
[patent_doc_number] => 10208096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Function suppression type of genetically-modified rhodocytin mutant
[patent_app_type] => utility
[patent_app_number] => 15/590268
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 52
[patent_no_of_words] => 11928
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590268
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590268 | Function suppression type of genetically-modified rhodocytin mutant | May 8, 2017 | Issued |
Array
(
[id] => 14243903
[patent_doc_number] => 10272134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Autologous HIV-1 proteins for the treatment of latent HIV-1 infection
[patent_app_type] => utility
[patent_app_number] => 15/589283
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15668
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589283
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/589283 | Autologous HIV-1 proteins for the treatment of latent HIV-1 infection | May 7, 2017 | Issued |
Array
(
[id] => 13127495
[patent_doc_number] => 10081668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
[patent_app_type] => utility
[patent_app_number] => 15/497822
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 18867
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 458
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/497822 | Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection | Apr 25, 2017 | Issued |
Array
(
[id] => 14868015
[patent_doc_number] => 20190284249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => BETA-CATENIN BARCODED PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/095879
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095879 | BETA-CATENIN BARCODED PEPTIDES | Apr 23, 2017 | Abandoned |
Array
(
[id] => 12117301
[patent_doc_number] => 20180000887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Treatment of Ascites'
[patent_app_type] => utility
[patent_app_number] => 15/491613
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3139
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15491613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/491613 | Treatment of Ascites | Apr 18, 2017 | Abandoned |
Array
(
[id] => 11851675
[patent_doc_number] => 20170226167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/490378
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10818
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490378
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490378 | MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES | Apr 17, 2017 | Abandoned |
Array
(
[id] => 16878005
[patent_doc_number] => 11028138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens
[patent_app_type] => utility
[patent_app_number] => 15/446240
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14785
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446240 | Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens | Feb 28, 2017 | Issued |
Array
(
[id] => 18412129
[patent_doc_number] => 11666656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Polymeric conjugates and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/079123
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 32
[patent_no_of_words] => 27515
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079123 | Polymeric conjugates and uses thereof | Feb 23, 2017 | Issued |
Array
(
[id] => 13926173
[patent_doc_number] => 20190046602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => METHODS OF TREATING ACUTE MYELOID LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 16/078696
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078696 | Methods of treating acute myeloid leukemia | Feb 22, 2017 | Issued |